Arbutus Biopharma Corporation (ABUS) Fell -5.26% or -0.3 To Price $5.4 On Thursday


Arbutus Biopharma Corporation (ABUS) fell -5.26% or -0.3 to $5.4. It is near 86957 shares traded, which is 33.84% compare to the average total volume 256958. The market cap of ABUS is $299.98 million. The year to date change is 4.59%. The 52 week price range is from $2.35 to $8.25. Price of ABUS have changed 16.33% during last week. It have changed 7.55% over last month, -24.50% over last 3 months, 56.16% over last 6 months and 128.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 5.48. It is 1.48% above current price. The 200-day Moving Averages for ABUS is 4.46. It is -17.41% below current price. The 52-week High is 8.25. It is 52.78% from the current price. The 52-week Low is 2.35. It is -56.48% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 1.84 on 2017-12-15. Short % to float is 1.06%. There are some statistics of ABUS. It is has market cap $299.98 million. The share outstanding is 55.55 million. The average volume is 256958. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -87.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -68.11%.


Tags:

Share this post